Evaluation of SeptiCyte RAPID, a host immune response assay, for triage of COVID-19 patients requiring hospitalization and potential ICU care
M. Montero(Universitat de València), Juan Pablo Horcajada(Evidence (Italy)), Thomas D. Yager(FedEx (United States)), Sílvia Gómez-Zorrilla(Hospital Universitario Virgen del Rocío), Krupa Navalkar, Itziar Arietta-Aldea(Hospital Del Mar), Joan Gómez‐Junyent(Hospital Del Mar), Maria del Mar Arenas(Hospital Del Mar), Robert Güerri‐Fernández(Instituto de Salud Carlos III), Immaculada López-Montesinos(Hospital Del Mar), Irene Hannet(Seattle University), James T. Kirk, Soledad Gonzalez Gallardo(Hospital Del Mar), Francisca Sánchez‐Martínez(Universitat Pompeu Fabra), Silvia Castañeda(Hospital Del Mar), Beatríz Bellosillo(Universitat Pompeu Fabra), Luisa Sorlí(Universitat Pompeu Fabra), Rebeca Rueda(Hospital Del Mar), Elena Sendra(Hospital Del Mar), Erica Torres(Hospital Del Mar), Iván Pelegrín(Hospital Del Mar), Judith Villar‐García(Universitat Pompeu Fabra), Max Hardy-Werbin(Hospital Del Mar)
Cited by 0
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
36th International Symposium on Intensive Care and Emergency Medicine
|Critical Care|2016|526
Betaine can eliminate the base pair composition dependence of DNA melting
|Biochemistry|1993|291